Analyst: Medtronic leadership changes could mean new acquisitions

03/5/2007 | Forbes

Medtronic's shuffling of its top executives could signal new acquisitions for the company but won't likely cause any major shifts in the company's strategic positioning, Goldman Sachs analyst Lawrence Keusch said. Another analyst said the company has "significant growth opportunities in the cardiac stent, diabetes care, spinal surgery and neurology units."

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN